|
Slamon, MD, PhD, director of clinical and translational research at the Jonsson Comprehensive Cancer Center, University of California at Los Angeles, indicated that the study provides further proof that targeted therapies still hold promise for improved efficacy <a href=https://nolvadex.one/>tamoxifen weight gain</a> |
|